IVD

Abbott Targets Drug and Alcohol-Impaired Drivers in New Collaboration

Intoximeters will market its alcohol testing products along with Abbott’s SoToxa Mobile Test System – a handheld oral fluid roadside testing solution that detects recent drug use.

Supplier Stories for the Week of August 11

Here’s what was new in the world of medical device suppliers during the week of August 11.

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Access to diagnostic assays is key to achievement of the World Health Organization’s infectious disease elimination goals.

Guardant Brings Home Strong Results as Liquid Biopsy Space Heats Up

The Redwood City, CA-based company said results of a study show the Guardant360 liquid biopsy assay can accurately detect microsatellite instability status as accurately as tissue biopsy.

LFI Devices: 3 Reasons for OEMs and Developers to Consider Automation

There is a compelling case to leverage automation in lateral flow immunoassay device manufacturing, and the top reasons may surprise you.

Exact Sciences and Genomic Health Merge to become Diagnostics Titan

Exact Sciences said it will acquire Redwood City, CA-based Genomic Health for $72 per share in a cash stock transaction valued at $2.8 billion, in a deal set to close by the end of the year.

How a New Sensor Could Diagnose Sepsis in 25 Minutes

MIT researchers designed a sensor that could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals.

Top 9 Companies in the Diagnostics Market

The diagnostics space has been filled with market clearances; collaborations and a dash of M&A. MD+DI has compiled a list of the most influential companies in the market.

ArcherDX in New Companion Diagnostic Collaboration with Ayala

The Denver, CO-based company will develop companion diagnostics with Ayala, that will target cancers bearing Notch activating mutations and fusions.

Biological Dynamics Wants to Shake up Diagnostics with Verita

The San Diego-based company has received a grant from the Bill & Melinda Gates Foundation to help in its goal to develop transformative diagnostics for tuberculosis and cancer.

Biodesix Looks to Become ‘the’ Lung Cancer Detection Co. With New Acquisition

The Boulder, CO-based company is extending its blood-based lung cancer diagnostic portfolio with the acquisition of Oncimmune’s laboratory and incidental pulmonary nodule malignancy test in the U.S.

Bracco Imaging ‘Ups’ its Precision Medicine Game with Blue Earth Diagnostics

The Milan, Italy based company will acquire Blue Earth Diagnostics for about $450 million.

Simple Blood Draw Detects Dangerous Pathogens

New findings show the potential clinical utility of its the Karius Test to detect pathogens causing serious infections using a simple blood draw.

CDx Diagnostics Founder and CSO Shares Company’s Journey

CDx Diagnostics began using artificial intelligence long before it became the popular or cool thing to do in medtech. Dr. Mark Rutenberg, CDx Founder and Chief Scientific Officer spoke to MD+DI about the evolution of the company and its current success.